Quipazine, a new type of antidepressant agent.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001923:Brain Chemistry; D003913:Dextroamphetamine / Q000494:pharmacology; D004357:Drug Synergism; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis; D010879:Piperazines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012701:Serotonin / Q000032:analysis; D013564:Sympathetic Nervous System / Q000187:drug effects; D013747:Tetrabenazine / Q000037:antagonists & inhibitors
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines; D011804:Quinolines; D012701:Serotonin; D012110:Reserpine; D003913:Dextroamphetamine; D009638:Norepinephrine; D013747:Tetrabenazine